KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
141 김진우 교수, 교과부 '글로벌연구실 사업'의 신규 지원과제에 선정! 과사무실 2009.06.25 13438
140 BK21 생물사업단, 2단계 사업 1,2,3차년도 연차평가 생물분야 연속 1위! 과사무실 2009.12.29 13438
139 [대덕넷] 임대식 교수 이달의 과기인상 수상 과사무실 2004.08.30 13469
138 남성훈 학생 외 2명 Bioneer Award (2004) 수상 과사무실 2005.02.22 13500
137 강은채 학생 창의활동상 수상 과사무실 2004.02.20 13503
136 강창원 교수, 한빛대상 수상! 과사무실 2011.09.28 13505
135 김학성 교수, 사람 항체 대체할 인공항체 기술 개발 과사무실 2012.02.15 13537
134 전상용 교수, 94회 일본화학회 정기학회 'Distinguished Lectureship Award' 수상 과사무실 2014.04.02 13565
133 전상용 교수, Cancer Research게제(2014.2) 과사무실 2014.03.12 13617
132 故 박태관 교수님의 명복을 빕니다. 과사무실 2011.04.11 13642
131 김은준 서연수 교수 우수교원 포상 과사무실 2004.02.13 13646
130 송세라, 박영균 학생 김보정 기초과학장학생으로 선발 과사무실 2006.09.12 13692
129 임대식 교수, 한국과학상 대통령상 수상(2016. 12. 27) file 생명과학과 2016.12.28 13712
128 [동아일보] 위암 당뇨 ‘맞춤 치료’ 길 열린다…SNP 지도 첫 완성 과사무실 2006.12.14 13726
127 김선창 교수 6월의 과학기술자 선정 과사무실 2003.09.08 13737
126 김학성 교수, Nature Communications 게재 (2014. 4) 과사무실 2014.04.24 13760
125 [경향신문] 뇌에서 시냅스 생성촉진 새 단백질 발견 -김은준교수팀 과사무실 2006.09.18 13789
124 최은비 박사과정 학생(김미영 교수 실험실) Oncogene 게재(2016.02) / Eun-Bee Choi, a Ph.D candidate in Prof. Mi-Young Kim’s lab published a paper in Oncogene (2016.02) 생명과학과 2016.03.07 13790
123 김세원 박사과정(강창원 교수 lab), Santorini Best Poster Award 수상! 과사무실 2011.06.17 13794
122 김근화 박사, 김승균 박사, 박상욱 박사, 2012년도 이공분야 '학문후속세대양성사업' 선정 과사무실 2013.01.02 13808
Board Pagination Prev 1 ... 11 12 13 14 15 16 17 18 19 20 ... 23 Next
/ 23